Stocks Health care NPLY
OTC · Health careNaploy Corp. (NPLY)
Naploy Corp. brought in $16.7K of revenue over the twelve months to April 30, 2026, up 282.0% from a year earlier. It posted a net loss of $12.2K. At April 30, 2026 it held $15.7K in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on May 21, 2026.
Key facts about Naploy Corp.
- Net worth
- Naploy Corp. reported shareholders' equity (book value: assets minus liabilities) of -$19.9K at April 30, 2026. We hold no current market value for it.
- Revenue and profit
- In fiscal 2025 revenue was $8K, with a net loss of $20.7K. Over the 12 months to April 30, 2026: revenue $16.7K, net loss $12.2K.
- Cash flow
- In fiscal 2025 operations used $21.2K of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on May 21, 2026 and covers the period to April 30, 2026. Open on SEC EDGAR
- Next earnings report
- Naploy Corp.'s next report is expected around October 26, 2026. That is an estimate from its filing rhythm, not a date the company has announced.
What Naploy Corp. does
Naploy Corp. is registered with the SEC under industry code SIC 8000 (Services-Health Services). Its shares trade on OTC under the ticker NPLY.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $8K | -$20.7K | -$0.01 | n/a |
| 2024 | $0 | -$20.3K | -$0.01 | n/a |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where NPLY ranks in Health care
Latest SEC filings
What Naploy Corp. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- May 21, 2026Quarterly report 10-Q · period to April 30, 2026Revenue rose 202% to $5K versus the same quarter last year; diluted EPS $0.00 versus $0.00.
- March 12, 2026Other event 8-K
- February 27, 2026Quarterly report 10-Q · period to January 31, 2026Revenue rose 110% to $4.5K versus the same quarter last year; diluted EPS $0.00 versus $0.00.
- December 2, 2025Quarterly report 10-Q · period to October 31, 2025Revenue rose 525% to $3.6K versus the same quarter last year; diluted EPS $0.00 versus $0.00.
- October 27, 2025
- July 9, 2025Auditor change 8-K/A
- June 5, 2025
- February 27, 2025
- December 3, 2024
- October 9, 2024
Insider trades
What the people running Naploy Corp. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
Questions about NPLY
What does Naploy Corp. do?
Naploy Corp. is a company in the Health care sector, listed on OTC as NPLY. Its shares trade on OTC under the ticker NPLY.
What is Naploy Corp.'s net worth?
Naploy Corp. reported shareholders' equity (book value: assets minus liabilities) of -$19.9K at April 30, 2026. We hold no current market value for it.
Is Naploy Corp. profitable?
No. Over the twelve months to April 30, 2026 it reported a net loss of $12.2K on revenue of $16.7K.
How much revenue does Naploy Corp. make?
Over the twelve months to April 30, 2026 Naploy Corp. reported revenue of $16.7K. That is 282.0% more than a year earlier.
When did Naploy Corp. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on May 21, 2026. It covers the period to April 30, 2026.
When is Naploy Corp.'s next earnings report?
Naploy Corp.'s next report is expected around October 26, 2026. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare NPLY with
Follow NPLY
Get an email when Naploy Corp. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Naploy Corp. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.